Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: Source dosimetry, treatment planning, equipment performance and in vivo verification techniques

Journal of Contemporary Brachytherapy

Volumn 4, Issue 2, 2012, Pages 81-91

  Palmer, Antony ^a,b   Bradley, David ^a   Nisbet, Andrew ^a,c  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Accuracy; Brachytherapy; Dosimetry; High dose rate (HDR); In vivo; Treatment planning.

Indexed keywords

BRACHYTHERAPY; DOSIMETRY; HUMAN; IN VIVO STUDY; IONIZATION CHAMBER; MONTE CARLO METHOD; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION PHYSICS; REVIEW; SEMICONDUCTOR; SYSTEMATIC REVIEW; THERMOLUMINESCENCE; TREATMENT PLANNING;

EID: 84864416530     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2012.29364     Document Type: Review

References (115)

1. ICRU Report 24. Determination of Absorbed Dose in a Patient Irradiated by Beams of X or Gamma Rays in Radiotherapy Procedures. International Commission on Radiation Units and Measurement, 1976.
2. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 1984; 23: 379-391. (Pubitemid 15028474)
3. Mijnheer BJ, Battermann JJ, Wambersie A. What degree of accuracy is required and can be achieved in photon and neutron therapy? Radiother Oncol 1987; 8: 237-252. (Pubitemid 17112902)
4. Van Dyk J, Barnett RB, Cygler JE et al. Commissioning and quality assurance of treatment planning computers. Int J Radiat Oncol Biol Phys 1993; 20: 261-273. (Pubitemid 23156973)
5. IAEA Safety Report Series No. 17. Lessons learned from accidental exposures in radiotherapy. International Atomic Energy Agency, Vienna 2000.
6. ICRP Publication 86. Prevention of accidents to patients undergoing radiation therapy. International Commission on Radiological Protection, 2000.
7. ICRP Publication 97. Prevention of high-dose-rate brachytherapy accidents. International Commission on Radiological Protection, 2005.
8. Thomadsen BR, Williamson JF, Rivard MJ et al. Anniversary paper: past and current issues, and trends in brachytherapy physics. Med Phys 2008; 35: 4708-4723.
9. Ibbott G, Ma CM, Rogers DWO et al. Anniversary Paper: Fifty years of AAPM involvement in radiation dosiemtry. Med Phys 2008; 35: 1418-1427. (Pubitemid 351457510)
10. Ibbott GS, Attix FH, Slowey TW et al. Uncertainty of calibrations at the accredited dosimetry calibration laboratories. Med Phys 1997; 24: 1249-1254. (Pubitemid 27366466)
11. DeWerd LA, Ibbott GS, Meigooni AS et al. A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO. Med Phys 2011; 38: 782-801.
12. Thomadsen B, Lin SW, Laemmrich P et al. Analysis of treatment delivery errors in brachytherapy using formal risk analysis techniques. Int J Radiat Oncol Biol Phys 2003; 57: 1492-1508. (Pubitemid 37443992)
13. Hoskin PJ, Bowne, PJ, Ostler P et al. High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiother Oncol 2003; 68: 285-288. (Pubitemid 38373429)
14. Whitaker M, Hruby G, Lovett A et al. Prostate HDR brachytherapy catheter displacement between planning and treatment delivery. Radiother Oncol 2011; 101: 490-494.
15. D'Souza D, Baldassarre F, Morton G et al. Imaging technologies for high dose rate brachytherapy for cervical cancer: a systematic review. Clin Oncol 2011; 23: 460-475.
16. Williamson JF, Dunscombe PB, Sharpe MB et al. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganiational symposium on "quality assurance of radiation therapy: challenges of advanced technology". Int J Radiat Oncol Biol Phys 2008; 71: S2-12.
17. Karaiskos P, Angelopoulos A, Sakelliou L et al. Monte Carlo and TLD dosimetry of an Ir-192 high dose-rate brachytherapy source. Med Phys 1998; 25: 1975-1984. (Pubitemid 28485221)
18. Kirov AS, Williamson JF, Meigooni AS et al. TLD, diode and Monte Carlo dosimetry of an Ir-192 source for high dose-rate brachytherapy. Phys Med Biol 1995; 40: 2015-2036.
19. Muller-Runkel R, Cho SH. Anisotropy measurements of a high dose rate Ir-192 source in air and in polystyrene. Med Phys 1994; 21: 1131-1134. (Pubitemid 24233840)
20. Zhang M, Zhang L, Yuan S et al. A study of experimental measurements of dosimetric parameters in HDR Ir-192 source. Med Dosim 2010; 35: 250-254.
21. Mishra V, Waterman FM, Suntharalingam N. Anisotropy of an 192iridium high dose rate source measured with a miniature ionization chamber. Med Phys 1997; 24: 751-755. (Pubitemid 27215212)
22. Zilio VO, Joneja OP, Popowski Y et al. Absolute depth-dose-rate measurements for an Ir-192 HDR brachytherapy source in water using MOSFET detectors. Med Phys 2006; 33: 1532-1539. (Pubitemid 43830241)
23. Toye WC, Das KR, Todd SP et al. An experimental MOSFET approach to characterize (192)Ir HDR source anisotropy. Phys Med Biol 2007; 52: 5329-5339. (Pubitemid 350153392)
24. Aldelaijan S, Mohammed H, Tomic N et al. Radiochromic film dosimetry of HDR (192)Ir source radiation fields. Med Phys 2011; 38: 6074-6083.
25. Butson MJ, Yu PKN, Cheung T et al. Radiochromic film for medical radiation dosimetry. Mat Sci Eng R 2003; 41: 61-120.
26. Sharma SD, Bianchi C, Conte L et al. Radiochromic film measurement of anisotropy function for high-dose-rate Ir-192 brachytherapy source. Phys Med Biol 2004; 49: 4065-4072. (Pubitemid 39242994)
27. Sureka CS, Sunny CS, Subbaiah KV et al. Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements. Phys Med Biol 2007; 52: 525-537. (Pubitemid 46646468)
28. Chiu-Tsao ST, Duckworth TL, Patel NS et al. Verification of Ir-192 near source dosimetry using GAFCHROMIC film. Med Phys 2004; 31: 201-207. (Pubitemid 38235390)
29. Baras P, Seimenis I, Kipouros P et al. Polymer gel dosimetry using a three-dimensional MRI acquisition technique. Med Phys 2002; 29: 2506-2516. (Pubitemid 35375448)
30. Williamson JF, Li Z. Monte Carlo aided dosimetry of the micro-Selectron pulsed and high dose-rate Ir-192 sources. Med Phys 1995; 22: 809-819.
31. Daskalov GM, Loffler E, Williamson JF. Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. Med Phys 1998; 25: 2200-2208. (Pubitemid 28530111)
32. Papagiannis P, Angelopoulos A, Pantelis E et al. Dosimetry comparison of Ir-192 sources. Med Phys 2002; 29: 2239-2246.
33. Sureka CS, Aruna P, Ganesan S et al. Computation of relative dose distribution and effective transmission around a shielded vaginal cylinder with Ir-192 HDR source using MCNP4B. Med Phys 2006; 33: 1552-1561. (Pubitemid 43830243)
34. Granero D, Pérez-Calatayud J, Ballester F. Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source. Radiother Oncol 2005; 76: 79-85. (Pubitemid 41096519)
35. Papagiannis P, Angelopoulos A, Pantelis E et al. Monte Carlo dosimetry of 60Co HDR brachytherapy sources. Med Phys 2003; 30: 712-721. (Pubitemid 36443973)
36. Lux I, Koblinger L. Monte Carlo Particle Transport Methods. Neutron and Photon Calculations. CRC Press, Boca Raton 1991.
37. Nath R, Anderson LL, Luxton G et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 1995; 22: 209-234.
38. Rivard MJ, Coursey BM, DeWerd LA et al. Update of AAPM Task Group No. 43 Report. A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004; 31: 633-674. (Pubitemid 38381028)
39. Williamson J, Coursey BM, DeWerd LA et al. Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources. Med Phys 1998; 25: 2269-2270. (Pubitemid 29006330)
40. Daskalov GM, Loffler E, Williamson JF. Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. Med Phys 1998; 25: 2200-2208. (Pubitemid 28530111)
41. Chandola RM, Tiwari S, Kowar MK et al. Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source. J Can Res Ther 2010; 6: 421-426.
42. Lliso F, Granero D, Pérez-Calatayud J et al. Dosimetric evaluation of internal shielding in a high dose rate skin applicator. J Contemp Brachyther 2011; 3: 32-35.
43. Uniyal SC, Sharma SD, Naithani UC. A dosimetry method in the transverse plane of HDR Ir-192 brachytherapy source using gafchromic EBT2 film. Phys Med 2012; 28: 129-133; DOI: 10.1016/j.ejmp.2011.03.005.
44. Deene YD, Reynaert N, Wagter CD. On the accuracy of monomer/polymer gel dosimetry in the proximity of a high-doserate Ir-192 source. Phys Med Biol 2001; 46: 2801-2825. (Pubitemid 33040982)
45. Guo PY, Adamovics JA, Oldham M. Characterization of a new radiochromic three-dimensional dosimeter. Med Phys 2006; 33: 1338-1345.
46. Wai P, Adamovics J, Krstajic N et al. Dosimetry of the microS-electron-HDR Ir-192 source using PRESAGETM and optical CT. Appl Radiat Isotopes 2009; 67: 419-422.
47. Guo P, Adamovics J, Oldham M. A practical three-dimensional dosimetry system for radiation therapy. Med Phys 2006; 33: 3962-3972. (Pubitemid 44505118)
48. Mostaar A, Hashemi B, Zahmatkesh MH et al. A basic dosimetric study of PRESAGE: the effect of different amounts of fabricating components on the sensitivity and stability of the dosimeter. Phys Med Biol 2010; 55: 903-912.
49. Gorjiara T, Hill R, Kuncic Z et al. Investigation of radiological properties and water equivalency of PRESAGE® dosimeters. Med Phys 2011; 38: 2265-2274.
50. Carrara M, Gambarlnl G, Scotti A et al. Fricke gel dosimetry for the measurement of the anisotropy function of an Ir-192 HDR brachytherapy source. Radiother Oncol 2010; 96: S516-S517.
51. Antonovic L, Gustafsson H, Carlsson GA et al. Evaluation of a lithium formate EPR dosimetry system for dose measurements around 192Ir brachytherapy sources. Med Phys 2009; 36: 2236-2247.
52. Issa F, Rahman ATA, Hugtenburg RP et al. Establishment of Ge-doped optical fibres as thermoluminescence dosimeters for brachytherapy. Appl Radiat Isotopes 2012; 70: 1158-1161; DOI: 10.1016/j.apradiso.2011.12.027.
53. Granero D, Pérez-Calatayud J, Pujades-Claumarchirant MC et al. Equivalent phantom sizes and shapes for brachytherapy dosimetric studies of 192Ir and 137Cs. Med Phys 2008; 35: 4872-4877.
54. Rivard MJ, Venselaar JL, Beaulieu L. The evolution of brachytherapy treatment planning. Med Phys 2009; 36: 2136-2153.
55. Rivard MJ, Beaulieu L, Mourtada F. Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms. Med Phys 2010; 37: 2645-2658.
56. AAPM Task Group No. 186 Model-based Dose Calculation Techniques in Brachytherapy: Status and Clinical Requirements for Implementation Beyond AAPM TG-43. The American Association of Physicists in Medicine; http://www.aapm.org/ org/structure/default.asp?committee-code=TG186 (accessed 24/04/2012).
57. Chavez-Aguilera N, Torres-Garcia E, Mitsoura E. Effect of chemical composition and density of the pelvic structure in intracavitary brachytherapy dosimetry. Rad Phys Chem 2011; 80: 349-353.
58. Parsai EI, Shang Z, Feldmeier JJ. A quantitative three-dimensional dose attenuation analysis around fletcher-Suit-Delclos due to stainless steel tube for high-dose-rate brachytherapy by Monte Carlo calculations. Brachytherapy 2009; 8: 318-323.
59. Uniyal SC, Naithani UC, Sharma SD et al. Radiochromic film dosimetry of rectal inhomogeneity and applicator attenuation in high dose rate brachytherapy of uterine cervix. J Appl Clin Med Phys 2012; 13: 3654.
60. Desbiens M, D'Amours M, Afsharpour H et al. Monte Carlo dosimetry of high dose rate gynaecologic interstitial brachytherapy. Radiother Oncol 2011; 99: S59.
61. Lakshminarayanan T, Subbaiah KV, Thayalan K et al. Suitability of point kernel dose calculation techniques in brachytherapy treatment planning. J Med Phys 2010; 35: 88-99.
62. DeMarco J, Park S, Kamrava M et al. A monte carlo analysis of HDR absorbed dose calculations using surface applicators. Int J Radiat Oncol Biol Phys 2011; 81: S895.
63. Zourari K, Pantelis E, Moutsatsos A et al. A virtual phantom/dicom protocol-based QA procedure for contemporary HDR 192Ir brachytherapy TPS. Radiother Oncol 2011; 99: S404-S405.
64. Zourari K, Pantelis E, Moutsatsos A et al. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part 1: Single sources and bounded homogeneous geometries. Med Phys 2010; 37: 649-661.
65. Petrokokkinos L, Zourari K, Pantelis E et al. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator. Med Phys 2011; 38: 1981-1992.
66. Citrin D, Ning H, Guion P et al. Inverse treatment planning based on MRI for HDR prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005; 61: 1267-1275. (Pubitemid 40340923)
67. Brooks S, Bownes P, Lowe G et al. Cervical brachytherapy utilizing ring applicator: Comparison of standard and conformal loading. Int J Radiat Oncol Biol Phys 2005; 63: 934-939. (Pubitemid 41400086)
68. Siauw T, Cunha A, Atamturk A et al. IPIP: A new approach to inverse planning for HDR brachytherapy by directly optimizing dosimetric indices. Med Phys 2011; 38: 4045-4051.
69. Kumar R, Sharma S, Vijaykumar C et al. A dose verification method for high-dose-rate brachytherapy treatment plans. J Can Res Ther 2008; 4: 173-177.
70. Astrahan MA. HDR quality assurance methods for personal digital assistants. Med Dosim 2004; 29: 166-172. (Pubitemid 39486004)
71. Carmona V, Pérez-Calatayud J, Lliso F et al. A program for the independent verification of brachytherapy planning system calculations. J Contemp Brachyther 2010; 2: 129-133.
72. Cormack RA. Quality assurance issues for computed tomography-, ultrasound-, and magnetic resonance imaging-guided brachytherapy. Int J Radiat Oncol Biol Phys 2008; 71: S136-S141. (Pubitemid 351491451)
73. Palmer A, Mzenda B. Performance assessment of the BEBIG MultiSource high dose rate brachytherapy treatment unit. Phys Med Biol 2009; 54: 7417-7434.
74. Sahoo N. Measurement of transit time of a remote after-loading high dose rate brachytherapy source. Med Phys 2001; 28: 1786-1790. (Pubitemid 32783224)
75. Calcina CS, de Almeida A, Rocha JR et al. Ir-192 HDR transit dose and radial dose function determination using alanine/EPR dosimetry. Phys Med Biol 2005; 50: 1109-1117. (Pubitemid 40477282)
76. Kutcher GJ, Coia L, Gillin M et al. Comprehensive QA for radiation oncology. Report of the AAPM Radiation Therapy Committee Task Group No. 40. Med Phys 1994; 21: 581-618. (Pubitemid 24129939)
77. Nath R, Anderson L, Meli JA et al. Code of practice for brachytherapy physics: Report of the AAPM Radiation The rapy Committee Task Group No. 56. Med Phys 1997; 24: 1557-1598. (Pubitemid 27449545)
78. IPEM Report 81. Physics aspects of quality control in radiotherapy. Institute of Physics and Engineering in Medicine, New York 1999.
79. Bidmead M, Briot E, Burger J et al. A practical guide to quality control of brachytherapy equipment. ESTRO Booklet No. 8. European Society for Therapeutic Radiology and Oncology, Brussels 2004.
80. Yewondwossen M. Characterization and use of a 2D-array of ion chambers for brachytherapy dosimetric quality assurance. Med Dosim 2011 [Epub ahead of print]; PMID: 22189031.
81. Devic S, Tomic N, DeBlois F. Brachytherapy TPS QA Using EBT Model GafChromic Film. Med Phys 2009; 36: 2528-2528.
82. Dempsey C. Lessons learned from a HDR brachytherapy well ionisation chamber calibration error. Australas Phys Eng Sci Med 2011; 34: 529-533.
83. Sarfehnia A, Kawrakow I, Seuntjens J. Direct measurement of absorbed dose to water in HDR 192Ir brachytherapy: water calorimetry, ionization chamber, Gafchromic film, and TG-43. Med Phys 2010; 37: 1924-1932.
84. Toni MP. New brachytherapy standards paradigm shift. In: Proceedings of an International Symposium on Standards, Applications and Quality Assurance in Medical Radiation Dosimetry (IDOS, 2010). International Atomic Energy Agency, Vienna 2011; 1: 393-406.
85. Quast U, Kaulich TW, Ahnesjö A et al. From reference air-kerma-rate to nominal absorbed dose-rate to water - Paradigm shift in photon brachytherapy: ISO new work item proposal. In: Proceedings of an International Symposium on Standards, Applications and Quality Assurance in Medical Radiation Dosimetry (IDOS, 2010). International Atomic Energy Agency, Vienna 2011; 1: 407-416.
86. Sarfehnia A, Seuntjens J. Development of a water calorimetry-based standard for absorbed dose to water in HDR 192Ir brachytherapy. Med Phys 2010; 37: 1914-1923.
87. Sibata CH, Gossman MS. Role of quality audits: view from North America. In: Quality and safety in radiotherapy (Imaging in medical diagnosis and therapy). Pawlicki T, Dunscombe P, Mundt AJ, Scaillet P (eds.). Taylor & Francis, Boca Raton 2010, pp. 161-165.
88. Elfrink RJM, Kolkman-Deurloo I-KK, van Kleffens HJ et al. Determination of the accuracy of implant reconstruction and dose delivery in brachytherapy in The Netherlands and Belgium. Radiother Oncol 2001; 59: 297-306. (Pubitemid 32429577)
89. Heeney C, McClean B, Kelly C. A dosimetric intercomparison of brachytherapy facilities in Ireland, Scotland and the North of England. Radiother Oncol 2005; 74: 149-156. (Pubitemid 40331871)
90. Roué A, Venselaar JL, Ferreira IH et al. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources. Radiother Oncol 2007; 83: 86-93.
91. Carlsson Tedgren A, Grindborg JE. Audit on source strength determination for HDR and PDR Ir-192 brachytherapy in Sweden. Radiother Oncol 2008; 86: 126-130.
92. Austerlitz C, Mota H, Almeida CE et al. Quality assurance of HDR 192Ir sources using a Fricke dosimeter. Med Phys 2007; 34: 1348-53. (Pubitemid 46555764)
93. Ochoa R, Gomes F, Ferreira IH et al. Design of a phantom for the quality control of high dose rate 192-Ir source in brachytherapy. Radiother Oncol 2007; 82: 222-228. (Pubitemid 46275140)
94. deAlmeida CE, Pereira AJ, Marechal MH et al. Intercomparison of calibration procedures for 192Ir HDR sources in Brazil. Phys Med Biol 1999; 44: N31-N38.
95. Qi ZY, Deng XW, Husang SM et al. Verification of the plan dosimetry for high dose rate brachytherapy using metal-oxide-semiconductor field effect transistor detectors. Med Phys 2007; 34: 2007-2013.
96. Lambert J, Nakano T, Law S et al. In vivo dosimeters for HDR brachytherapy: a comparison of a diamond detector, MOSFET, TLD, and scintillation detector. Med Phys 2007; 34: 1759-1765. (Pubitemid 46669170)
97. Das R, Toye W, Kron T et al. Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer. Australas Phys Eng Sci Med 2007; 30: 178-184. (Pubitemid 47611251)
98. Hsu SM, Yeh CY, Yeh TC et al. Clinical application of radiophotoluminescent glass dosimeter for dose verification of prostate HDR procedure. Med Phys 2008; 35: 5558-5564.
99. Huston AL, Justus BL, Falkenstein PL et al. Remote optical fiber dosimetry. Nucl Instr Meth Phys Res B 2001; 184: 55-67. (Pubitemid 32903710)
100. Anderson CE, Nielson SK, Greilich S et al. Characterization of a fiber-coupled Al2O3:C luminescence dosimetry system for online in vivo dose verification during 192Ir brachytherapy. Med Phys 2009; 36: 708-718.
101. Suchowerska N, Abolfathi P, Cartwright L et al. Clinical use of a fibre optic dosimeter array in brachytherapy: urethral dosimetry and rectal wall dose mapping. Radiother Oncol 2010; 96: S209.
102. Kertzscher G, Andersen CE, Siebert FA et al. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion. Radiother Oncol 2011; 100: 456-462.
103. Therriault-Proulx F, Briere TM, Mourtada F et al. A phantom study of an in vivo dosimetry system using plastic scintillation detectors for real-time verification of 192Ir HDR brachytherapy. Med Phys 2011; 38: 2542-2551.
104. Terriault-Proulx F, Beddar S, Briere TM et al. Technical note: removing the stem effect when performing Ir-192 HDR brachytherapy in vivo dosimetry using plastic scintillation detectors: a relevant and necessary step. Med Phys 2011; 38: 2176-2179.
105. Kinhikar RA, Sharma PK, Tambe CM et al. Dosimetric evaluation of a new OneDose MOSFET for Ir-192 energy. Phys Med Biol 2006; 51: 1261-1268. (Pubitemid 43267193)
106. Haughey A, Coalter G, Mugabe K. Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy. Australas Phys Eng Sci Med 2011; 34: 361-366.
107. Reniers B, Landry G, Eichneer R et al. In vivo dosimetry for gynaecological brachytherapy based on a novel radpos system. Radiother Oncol 2011; 99: S118-S119.
108. Able CM, Bright M, Frizzell B et al. Quality control of high-dose-rate brachytherapy: Treatment delivery analysis using statistical process control. Brachytherapy 2010; 9: S64-65.
109. Anton M, Wagner D, Selbach HJ et al. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer - a phantom study. Phys Med Biol 2009; 54: 2915-2931.
110. Holly R, Morton GC, Sankreacha R et al. Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy. Brachytherapy 2011; 10: 299-305.
111. Foster W, Cunha JAM, Hsu IC et al. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy. Int J Radiat Oncol Biol Phys 2011; 80: 85-90.
112. Meilán Bermejo E, Del Moral F, Pereira L et al. Calibration and use of Gafchromic EBT2 films for QA in HDR brachytherapy. Radiother Oncol 2011; 99: S405.
113. Hassouna A, Bahadur Y, Constantinescu C et al. Role of invivo diodes dosimetry for critical organ dose evaluation in HDR brachytherapy of cervix cancer. Radiother Oncol 2011; 99: S401-S402.
114. Toye W, Das R, Kron T et al. An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry. Radiother Oncol 2009; 91: 243-248.
115. Swamidas JV, Sharma S, Mahantshetty UM et al. Risk assessment in intracavitary brachytherapy based on failure mode and effective analysis. Brachytherapy 2010; 9: S48.